...
首页> 外文期刊>Clinical and Translational Gastroenterology >A novel prognostic marker and immunogenic membrane antigen: prohibitin (PHB) in pancreatic cancer
【24h】

A novel prognostic marker and immunogenic membrane antigen: prohibitin (PHB) in pancreatic cancer

机译:胰腺癌的一种新的预后标志物和免疫原性膜抗原:禁止素(PHB)

获取原文
           

摘要

Background Previous study, using immunoblotting with IgG and membrane proteins, identified prohibitin (PHB) as a potential immunogenic membrane antigen. Now, investigate PHB expression and biological functions in pancreatic cancer. Methods PHB expression was analysed in PDAC cell lines, normal pancreas tissues, cancer tissues, PDAC patient sera and healthy volunteer sera using QRT-PCR, Western blotting, IHC, and ELISA, and a survival analysis and a COX regression analysis were performed. Low and high PHB expression levels were accomplished using RNA interference technology and gene transfer techniques. Cell proliferation, migration, and invasion, apoptosis-related proteins were assessed 48?h after transfection. Results PHB was generally expressed in the 8 tested PDAC cell lines. PHB was significantly increased in PDAC tissues and negatively correlated with overall survival ( p ?
机译:背景技术先前的研究使用IgG和膜蛋白进行免疫印迹,将禁止素(PHB)确定为潜在的免疫原性膜抗原。现在,研究PHB在胰腺癌中的表达和生物学功能。方法采用QRT-PCR,Western blotting,IHC和ELISA法分析PDAC细胞系,正常胰腺组织,癌组织,PDAC患者血清和健康志愿者血清中的PHB表达,并进行生存分析和COX回归分析。使用RNA干扰技术和基因转移技术可实现低和高PHB表达水平。转染后48小时,评估细胞增殖,迁移和侵袭,凋亡相关蛋白。结果PHB通常在8个测试的PDAC细胞系中表达。在PDAC组织中,PHB显着升高,与总生存率呈负相关(p 0.01)。 PHB是PDAC的独立预后因素(p <0.01)。 PDAC患者血清中的PHB升高(p <0.01)。 siRNA-PHB减少了细胞的生长,迁移和侵袭。但是,PHB过表达导致相反的效果。 Western印迹和流式细胞仪分析揭示了siRNA-PHB PDAC细胞的凋亡抑制。结论PHB在调节恶性表型和凋亡诱导中起着关键作用,这可能是一种新的预后指标和靶向治疗PDAC的候选药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号